SAR-260301 | m-entrepreneurship.com

Product Name :
SAR-260301

Search keywords :
SAR-260301

drugId :
null

Target Vo:
Phosphatidylinositol 3 kinase beta

Target Vo Short Name :
PI3Kβ

Moa_Name:
Phosphatidylinositol 3 kinase beta inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sanofi

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NLRP3 Antibody
Src Antibody
Cleaved-Caspase 9 Antibody: Cleaved-Caspase 9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to Cleaved-Caspase 9. It can be used for WB, IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts